Welcome to Next.cancer.gov - NCI Experimental Therapeutics (NExT)

next.cancer.gov

Description: NExT Cancer. Who can apply to the NExT Program?...

Google PR 5

Trustworthiness Excellent
Avg. Daily Visitors N/A

Child Safety Excellent
Avg. Daily Pageviews N/A

Privacy Excellent

NCI Experimental Therapeutics (NExT)

Next.cancer.gov: get to the top rated NExT Cancer pages and content popular with USA-based Next.cancer.gov users or check the following digest to find out more. Next.cancer.gov is a malware-free website without age restrictions, so you can safely browse it. It seems that NExT Cancer team are just starting to conquer the social media and they have already achieved a promising result — 54 user activities so far (Twitter dominates with around 50% of all user reactions). Next.cancer.gov is hosted with National Cancer Institute in United States. NExT Cancer traffic is not yet estimated by Alexa.

Visit next.cancer.gov

Domain info

Location:	United States
Registrant:	REDACTED FOR PRIVACY
Hosted by:	National Cancer Institute
Subnetworks:	129.43.254.105

Social Media Activities

Facebook likes: -
Twitter mentions: 27
Google pluses: -
LinkedIn mentions: 20
Pinterest pins: -
StumbleUpon views: 7

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Next.cancer.gov popular pages to visit

NCI Experimental Therapeutics (NExT) Who can apply to the NExT Program? In general, domestic or foreign, public or private, non-profit or for-profit organizations, and investigators therein, are eligible to submit NExT Applications. What...

Discovery | NExT Resources | NExT The NExT Screening Libraries (Pre-plated Copies Available) How to Access The NExT Diversity Libraries Submit a proposal to the NExT Program to collaborate with the Chemical Biology Consortium on an on...

Discovery | NCI Experimental Therapeutics (NExT) Director: Dr. Gunda I. Georg The University of Minnesota Chemical Diversity Center is based primarily on the capabilities of the Institute for Therapeutics Discovery and Development (ITDD) and the De...